Responses
Basic tumor immunology
Original research
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.